Latest From Biotech Now

Docs to FDA: Biosimilars should have different names than branded drugs

shutterstock_1092009

Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists to FDA Commissioner Margaret Hamburg saying that biosimilars “must have distinguishable nonproprietary names. The FDA drafted a set of rules for biosimilars in 2012, sparking a debate on whether those drugs should carry the same generic names as the originator products. Now, some doctors are weighing in on the issue, urging the FDA to require biosimilars to have distinguishable names. The physicians argued that using different Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

National Immunization Awareness Month

Vaccination

August is National Immunization Awareness Month, providing a reminder of the importance of proper vaccination just as kids are heading back to school. Schools are a prime venue for transmitting vaccine-preventable diseases, and school-age children can further spread disease to their families and others with whom they come in contact. As children get older, they are at an increased risk for some infections, and the protection from some childhood vaccines begins to fade, requiring a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

A Refreshing Look at the NEW Potato

admin-ajax (3)

The Capital Press ran an op-ed from Idaho farmer Lisa Patterson about new potato technology that will reduce black spot bruising and browning when cut and help prevent unnecessary waste. Patterson is a member of the Truth About Trade and Technology Global Farmer Network. In her op-ed, Lisa addresses an issue faced by all moms, food waste. “You go to the grocery store, buy a sack of potatoes, and come home to get that meal Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

Seattle Times Commentary: New Approaches Needed to Fight Ebola

scientist-eyedropper

In the Seattle Times this week, BIO Ventures for Global Health President Jennifer Dent offered commentary on the need for new drug development models to develop treatments for Ebola, arguing that conventional approaches are not working for neglected tropical diseases. Partnerships involving drug companies as well as academic, non-profit, and government stakeholders are needed. Dent offers the WIPO Re:Search consortium as an example: In 2011, BIO Ventures for Global Health established a partnership with the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Latin America Program Highlights

LatinAmerica_205x100_Thumbnail copy

BIO Latin America is just one short month away, September 9-11 in Rio de Janeiro, Brazil, and with this in mind BIO has announced the preliminary program as well as an initial list of presenting companies. Program topics include: Regional Biotech Development: Frameworks for Innovation Incentivizing Entrepreneurship and Investment in Latin America The Innovation Ecosystem in Brazil: From Biofuels to Biotherapeutics Tech Transfer: Industry and University Collaborations Regional Regulations for Biotherapeutics Clinical Trials: Addressing Challenges Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,